Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Stem Cell News: Breaking Stem Cell News, Comments and Articles. - Page: 4

08:51 EDT 23rd April 2014 | BioPortfolio

Stem Cell News - Page: 4Twitter RSS

Read the latest Stem Cell News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Stem Cell.

Search or Follow Our Stem Cell - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Stem Cell - Page: 4 News.
You can also follow our Stem Cell - Page: 4 news stories on Twitter: @stemcellnews

Showing "stem embryonic progenitor cell" News Articles 76 to 100 of 8,700+

Tuesday 22nd April 2014

Neuralstem's Cell Therapy Is Working, And This Is Just The Beginning

By Jason Napodano: Back in February 2014, we wrote an article for Seeking-Alpha reviewing the recently published Phase 1 data on Neuralstem's (CUR) NSI-566 for the treatment of Amyotrophic Lateral Sclerosis ("ALS"). This article is now exclusive to PRO subscribers, but we can point investors to the full peer-reviewed paper published in the Annals of Neurology (Feldman et al, 2014) for a comprehens...

PRESENTATION ON NW BIO'S DCVAX-DIRECT TRIAL ANNOUNCED FOR ASCO ANNUAL MEETING

BETHESDA, Md., April 22, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that ASCO (the American Society for Clinical Oncology) has announced in its Annual Meeting program that the Company will present its DCVax-Direct clinical trial and technology in a...

Combination of Alcohol and Tobacco Increases Risk of Esophageal Cancer

BETHESDA, Md., April 22, 2014 /PRNewswire-USNewswire/ -- The rate of developing esophageal squamous cell carcinoma (ESCC) nearly doubles in those who both smoke and drink compared to those who only smoke or drink, according to new research published in The American Journal of Gastroenterology. Although multiple studies have identified risk factors for the development of ESCC, notably, exposure to...

BioCision's temperature standardization technology to be used in TxCell Phase IIb cell therapy clinical trial

BioCision has announced that several of the company's products used to support temperature control, as well as processing and handling of cell therapy products, will be used in a Phase IIb clinical trial conducted by TxCell.

Researchers achieve higher solar-cell efficiency with zinc-oxide coating

(Phys.org) —Engineering researchers at the University of Arkansas have achieved the highest efficiency ever in a 9 millimeter-squared solar cell made of gallium arsenide. After coating the cufflink-sized cells with a thin layer of zinc oxide, the r...

Platinum Soursop, a Popular Health and Immunity Booster, Now With 1 Extra Bottle Offer On Select Packages

Platinum Soursop, which has always been 100% pure and natural, is now offered in an increased dosage. In each capsule is the strongest Brazilian Graviola extract in the market. Los Angeles, CA (PRWEB) April 22, 2014 The pure extract of Brazilian Graviola is making health experts very optimistic about its bountiful effects on a person’s health and overall well-being. Although Brazilian Graviola...

Norman Borlaug Ringtone

It has been almost a month since we released the Play it Hard music video with Nobel laureate Dr. Norman Borlaug, and the video has received over 9,000 views (when you count CIMMYT’s channel as well as ours)! We’re really pleased to hear...

New way to enhance nerve growth following injury discovered

A mechanism to promote growth in damaged nerve cells as a means to restore connections after injury has been uncovered by scientists who have discovered a key molecule that directly regulates nerve cell growth in the damaged nervous system. "We made...

Ambit Biosciences to Announce First Quarter 2014 Financial Results

SAN DIEGO, April 22, 2014 /PRNewswire/ -- Ambit Biosciences (Nasdaq: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced it will report first quarter operational results after closing of the NASDAQ Global Market on Tuesday, May 6, 2014. A conference call hosted by Michae...

Mitochondrial Repair May Be Culprit Behind Muscle Weakness In Mitochondrial Diseases, Alcoholics

April Flowers for redOrbit.com - Your Universe Online Long-time alcoholics and patients with mitochondrial disease both suffer with muscle weakness, but it wasn't until a new study from Thomas Jefferson University that a common link was found. According to the findings, described in The Journal of Cell Biology, the link involves mitochondria that are unable to self-repair. This information gives...

For an immune cell, microgravity mimics aging

(Medical Xpress)—Telling someone to "act your age" is another way of asking him or her to behave better. Age, however, does not always bring improvements. Certain cells of the immune system tend to misbehave with age, leaving the elderly more vulne...

BioLife Solutions to Launch biologistex(SM) Service at 20th ISCT Annual Meeting; Precision Thermal Shippers with Embedded Payload Temperature Monitoring and GPS Location Tracking

BOTHELL, Wash., April 22, 2014 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced that it will launch biologistex service, a new integrated platform of a cloud-based information se...

Scientists uncover key mechanism that regulates nerve cell growth in damaged nervous system

New research published today out of the University of Calgary's Hotchkiss Brain Institute uncovers a mechanism to promote growth in damaged nerve cells as a means to restore connections after injury. Dr. Doug Zochodne and his team have discovered a k...

Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014

Recently added to the BioPortfolio report store, Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014 is a new report from GlobalData published on 2014-04-14. This 71-page report is available in PDF from $2500. Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Natural Killer Cell Lymphomas Global Clinical Trials...

Metastatic Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H1, 2014

Recently added to the BioPortfolio report store, Metastatic Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H1, 2014 is a new report from GlobalData published on 2014-04-14. This 121-page report is available in PDF from $2500. Metastatic Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial r...

Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014

Recently added to the BioPortfolio report store, Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014 is a new report from GlobalData published on 2014-04-14. This 82-page report is available in PDF from $2500. Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Ovarian Cancer Global Clinical Trials Review, H1,...

Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014

Recently added to the BioPortfolio report store, Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 is a new report from GlobalData published on 2014-04-14. This 201-page report is available in PDF from $2500. Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Renal Cell Carcinoma Global Clinical...

Papillary Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014

Recently added to the BioPortfolio report store, Papillary Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 is a new report from GlobalData published on 2014-03-30. This 284-page report is available in PDF from $2500. Papillary Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Papillary Renal Cell Carcinoma Global Clinical Tri...

Scientists discover a new way to enhance nerve growth following injury

New research published today out of the University of Calgary's Hotchkiss Brain Institute (HBI) uncovers a mechanism to promote growth in damaged nerve cells as a means to restore connections after injury. Dr. Doug Zochodne and his team have discover...

Monday 21st April 2014

SIRT1 protein necessary for telomere elongation and genome integrity during cell reprogramming

Cell reprogramming converts specialised cells such as nerve cells or skin cells towards an embryonic stem cell state. This reversal in the evolutionary development of cells also requires a reversal in the biology of telomeres, the structures that pro...

Shiseido Cell-Processing and Expansion Center to be opened in Kobe, Japan

Shiseido Co., Ltd. announces plans to open the Shiseido Cell-Processing and Expansion Center (SPEC) on May 1, 2014. The center, located in the in the Kobe Biomedical Innovation Cluster in Kobe, Japan, will centralize research and development on hair...

Shiseido Opens Research Facility Dedicated to Hair Regeneration

- Shiseido Cell-Processing and Expansion Center - Shiseido Co., Ltd. (TOKYO:4911) announces plans to open the Shiseido Cell-Processing and Expansion Center (SPEC) on May 1, 2014. The center, located in the in the Kobe Biomedical Innovation Cluster in Kobe, Japan, will centralize research and development on hair regenerative medicine with an aim...

Medical News Today: Stem cells show bizarre absorption property 'not seen before in cells'

Researchers have found that stem cell nuclei demonstrate an unusual, counterintuitive property never seen before in cells - auxeticity - where stretching causes them to expand.

Cell Therapeutics to Report First Quarter 2014 Financial Results on April 29, 2014

SEATTLE, April 22, 2014 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced today that it will report its first quarter 2014 financial results on Tuesday, April 29, 2014, after the close of the U.S. financial markets. Following the announcement, members of the management team will host a webcast conference call to discuss the results and provide a general corporate...

Profiling the repertoire of T-cell receptor beta-chain variable genes in peripheral blood lymphocytes from subjects who have recovered from acute hepatitis B virus infection


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement